Axel Hinke Selected Research

2- (3- (2- aminoethyl)- 1H- indol- 5- yloxy)acetyl- L- tyrosyl- glycinamide (IS 159)

8/2014

Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Axel Hinke Research Topics

Disease

16	Colorectal Neoplasms (Colorectal Cancer) 09/2021 - 09/2007
15	Neoplasms (Cancer) 09/2021 - 08/2005
14	Breast Neoplasms (Breast Cancer) 06/2020 - 12/2005
10	Multiple Myeloma 01/2020 - 06/2004
6	Adenocarcinoma 01/2022 - 08/2006
6	Rectal Neoplasms (Rectal Cancer) 03/2021 - 10/2002
6	Disease Progression 02/2016 - 09/2009
6	Infections 01/2016 - 10/2004
5	Prostatic Neoplasms (Prostate Cancer) 02/2015 - 03/2004
4	Nausea 01/2018 - 01/2005
4	Vomiting 01/2018 - 01/2005
4	Lymphoma (Lymphomas) 01/2016 - 02/2011
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 06/2003
3	Stomach Neoplasms (Stomach Cancer) 01/2022 - 10/2011
3	Pathologic Complete Response 10/2020 - 06/2009
3	Stomatitis 01/2018 - 02/2011
3	Neutropenia 02/2015 - 10/2004
3	Pancreatic Neoplasms (Pancreatic Cancer) 10/2013 - 08/2006
3	Thrombocytopenia (Thrombopenia) 05/2013 - 11/2002
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2016 - 04/2013
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2013 - 11/2002
2	Alopecia (Baldness) 04/2013 - 06/2003
2	Hand-Foot Syndrome 08/2010 - 10/2002
2	Body Weight (Weight, Body) 08/2007 - 06/2003
1	Thrombocytosis (Thrombocythemia) 09/2021
1	Hyperthermia 03/2021
1	Squamous Cell Carcinoma of Head and Neck 10/2020
1	Pain (Aches) 01/2020
1	Exanthema (Rash) 12/2017
1	Cardiotoxicity 01/2017
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2016
1	Anastomotic Leak 11/2015
1	Neoplasm Metastasis (Metastasis) 02/2015

Drug/Important Bio-Agent (IBA)

12	Capecitabine (Xeloda)FDA Link 02/2016 - 10/2002
10	Trastuzumab (Herceptin)FDA Link 01/2022 - 08/2007
9	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 09/2007
9	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 08/2005
8	Bevacizumab (Avastin)FDA Link 06/2021 - 08/2011
6	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 09/2007
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 11/2005
5	AnthracyclinesIBA 01/2018 - 11/2002
4	Leucovorin (Folinic Acid)FDA Link 10/2015 - 09/2007
4	Epirubicin (Ellence)FDA LinkGeneric 07/2013 - 06/2009
4	Melphalan (Alkeran)FDA LinkGeneric 09/2010 - 10/2004
3	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 08/2006
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 04/2009
3	Thalidomide (Thalomid)FDA Link 01/2020 - 04/2009
3	fludarabineIBA 01/2016 - 11/2002
3	Rituximab (Mabthera)FDA Link 01/2016 - 11/2002
3	Bendamustine Hydrochloride FDA Link 01/2016 - 04/2013
3	Prostate-Specific Antigen (Semenogelase)IBA 02/2015 - 06/2009
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2015 - 10/2004
3	Gemcitabine FDA Link 10/2013 - 08/2006
3	Cetuximab (Erbitux)FDA Link 02/2011 - 03/2008
3	Prednisolone (Predate)FDA LinkGeneric 09/2010 - 11/2005
2	IpilimumabIBA 01/2022 - 06/2020
2	Docetaxel (Taxotere)FDA Link 01/2022 - 10/2020
2	NivolumabIBA 01/2022 - 06/2020
2	Biomarkers (Surrogate Marker)IBA 09/2021 - 01/2018
2	Circulating Tumor DNAIBA 01/2021 - 12/2020
2	Neurokinin-1 Receptor AntagonistsIBA 01/2018 - 05/2016
2	ErbB Receptors (EGF Receptor)IBA 12/2017 - 01/2017
2	Hormones (Hormone)IBA 01/2017 - 02/2015
2	human ERBB2 proteinIBA 01/2017 - 08/2007
2	Capsules (Microcapsules)IBA 08/2014 - 06/2009
2	Vincristine (Oncovin)FDA LinkGeneric 04/2013 - 11/2005
2	Irinotecan (Camptosar)FDA LinkGeneric 10/2011 - 08/2011
2	taxaneIBA 08/2010 - 08/2007
2	Amifostine (Ethyol)FDA LinkGeneric 09/2009 - 06/2003
2	Carboplatin (JM8)FDA LinkGeneric 09/2007 - 08/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	pazopanib FDA Link 01/2022
1	RamucirumabIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	tremelimumabIBA 10/2020
1	durvalumabIBA 10/2020
1	ametantrone (HAQ)IBA 01/2020
1	Guanosine Diphosphate (GDP)IBA 01/2020
1	ixazomibIBA 01/2020
1	Fibroblast Growth Factor 7 FDA Link 01/2018
1	Panitumumab (Vectibix)FDA Link 12/2017
1	Doxycycline (Periostat)FDA LinkGeneric 12/2017
1	Erythromycin (Erycette)FDA LinkGeneric 12/2017
1	purineIBA 01/2016

Therapy/Procedure

28	Drug Therapy (Chemotherapy) 01/2022 - 06/2004
25	Therapeutics 01/2022 - 11/2005
7	Radiotherapy 02/2015 - 10/2002
6	Adjuvant Chemotherapy 01/2017 - 06/2010
5	Combination Drug Therapy (Combination Chemotherapy) 10/2015 - 08/2005
5	Prostatectomy (Retropubic Prostatectomy) 02/2015 - 03/2004
3	Chemoradiotherapy 10/2010 - 06/2003
3	Stem Cell Transplantation 09/2010 - 06/2004
2	Radioimmunotherapy 01/2022 - 10/2020
2	Neoadjuvant Therapy 03/2021 - 11/2015
2	Adjuvant Radiotherapy 08/2013 - 06/2009
1	Immunotherapy 06/2020
1	Hematopoietic Stem Cell Transplantation 01/2018
1	Induction Chemotherapy 11/2016
1	Autologous Transplantation 11/2016